Eduardo Anaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eduardo Anaya has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra E. Grier
The Jackson Laboratory, Bar Harbor, Maine
1 shared publication - Francesca Pala
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
1 shared publication - Jennifer Heimall
15Division of Allergy and Immunology, https://ror.org/01z7r7q48Children’s Hospital of Philadelphia, Philadelphia, PA, USA
1 shared publication - Kayla Amini
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health 2 , Bethesda, MD
1 shared publication - Luigi Daniele Notarangelo
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States
1 shared publication - Manar Abdalgani
Columbia University Vagelos College of Physicians and Surgeons, Columbia University 4 Department of Pediatrics New York, NY
1 shared publication
Latest Publications
- Open Access
- 6 March 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (3) , e20250169
Unmanipulated bone marrow infusion without conditioning can rescue RECQL4 −/− severe combined immunodeficiency
Mutations in DNA helicase RECQL4 can cause immunodeficiency, including SCID. The T cell defects are intrinsic to the hematopoietic system and amenable to hematopoietic stem cell transplant. Radiosensitivity due to DNA repair defects limits conditioning regimen options.
- 6 March 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (3) , e20250169
Open AccessUnmanipulated bone marrow infusion without conditioning can rescue RECQL4 −/− severe combined immunodeficiency
Mutations in DNA helicase RECQL4 can cause immunodeficiency, including SCID. The T cell defects are intrinsic to the hematopoietic system and amenable to hematopoietic stem cell transplant. Radiosensitivity due to DNA repair defects limits conditioning regimen options.